Florida Cancer Specialists North

Fort Myers, Florida 33916

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Chemotherapeutic Toxicity, Colorectal Cancer Metastatic, Metastatic Breast Cancer, Myelosuppression-Adult

Studies at this site

• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): — Stopped early
• Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy — Completed
• Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer — Completed